Download PDF
1 / Pages

Other users also viewed these articles

Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society] Juan Pedro-Botet; Vivencio Barrios; Víctor Sánchez-Margalet; Juan Tamargo; Francisco Arrieta; José Mª Gámez; José Antonio Gimeno-Orna; Carlos Escobar; Juan José Gómez-Doblas; Antonio Pérez;
Endocrinol Diabetes Nutr. 2023;70 Supl 1:51-62
First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: A retrospective observational study (RETOSS-ENDO) Antonio Pérez Pérez; Emilio Ortega Martínez de Victoria; Francisco Arrieta Blanco; Assumpta Caixàs Pedragós; Estefanía Santos Mazo; Pablo Fernandez-Catalina; Sergio Martínez-Hervas; José Antonio López-Medina; Lorena Suárez-Gutiérrez; Juan Ramón Urgeles Planelles; Sònia Gatell Menchén; Francisco Tinahones Madueño;
Endocrinol Diabetes Nutr. 2022;69:540-2
Consensus document for lipid profile testing and reporting in Spanish clinical laboratories Teresa Arrobas Velilla; Carlos Guijarro; Raquel Campuzano Ruiz; Manuel Rodríguez Piñero; José Francisco Valderrama Marcos; Antonio M. Botana López; Ana Morais López; José Antonio García Donaire; Juan Carlos Obaya; Luis Castilla Guerra; Vicente Pallares Carratalá; Isabel Egocheaga Cabello; Mercedes Salgueira Lazo; María Mar Castellanos Rodrigo; José María Mostaza Prieto; Juan José Gómez Doblas; Antonio Buño Soto;
Endocrinol Diabetes Nutr. 2023;70:501-10